First Time Loading...

Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 21.21 CNY -0.19% Market Closed
Updated: May 7, 2024
Section:
 

Relative Value

The Relative Value of one Shenzhen Kangtai Biological Products Co Ltd stock under the Base Case scenario is 40.75 CNY. Compared to the current market price of 21.21 CNY, Shenzhen Kangtai Biological Products Co Ltd is Undervalued by 48%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

Relative Value
Base Case
40.75 CNY
Undervaluation 48%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

7.7
P/S
P/S
Price to Sales
7.7
vs History
95
vs Industry
54
Median 3Y
11.2
Median 5Y
14.3
Industry
8.3
Forward
6.2
More Details
65.6
P/E
P/E
Price to Earnings
65.6
vs History
52
vs Industry
3
Median 3Y
62.5
Median 5Y
69.9
Industry
26.8
Forward
28.7
More Details
26
P/OCF
P/OCF
Price to OCF
26
vs History
88
vs Industry
7
Median 3Y
39.8
Median 5Y
63.2
Industry
23.3
More Details
165.1
P/FCFE
P/FCFE
Price to FCFE
165.1
vs History
23
vs Industry
1
Median 3Y
24.5
Median 5Y
-27.7
Industry
21.4
More Details
2.5
P/B
P/B
Price to Book Value
2.5
vs History
95
vs Industry
38
Median 3Y
4.1
Median 5Y
7.9
Industry
2.6
More Details
8.2
EV/S
EV/S
Enterprise Value to Sales
8.2
vs History
93
vs Industry
43
Median 3Y
11.3
Median 5Y
13.9
Industry
7.5
Forward
6.6
More Details
10
EV/GP
EV/GP
Enterprise Value to Gross Profit
10
vs History
95
vs Industry
40
Median 3Y
13.9
Median 5Y
16.6
Industry
9.2
More Details
86.2
EV/EBITDA
EV/EBITDA
Enterprise Value to EBITDA
86.2
vs History
46
vs Industry
1
Median 3Y
91.4
Median 5Y
83.7
Industry
4.5
Forward
15.7
More Details
86.2
EV/EBIT
EV/EBIT
Enterprise Value to EBIT
86.2
vs History
46
vs Industry
1
Median 3Y
91.4
Median 5Y
83.7
Industry
4.4
Forward
19.4
More Details
27.7
EV/OCF
EV/OCF
Enterprise Value to OCF
27.7
vs History
88
vs Industry
6
Median 3Y
40.6
Median 5Y
63.3
Industry
5.6
More Details
208.9
EV/FCFF
EV/FCFF
Enterprise Value to FCFF
208.9
vs History
28
vs Industry
1
Median 3Y
-52.6
Median 5Y
-52.6
Industry
3.4
More Details
1.9
EV/IC
EV/IC
Enterprise Value to IC
1.9
vs History
95
vs Industry
50
Median 3Y
3.4
Median 5Y
6.7
Industry
5
More Details

Multiples Across Competitors

Competitors Multiples
Shenzhen Kangtai Biological Products Co Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
CN
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
23.7B CNY 7.7 65.6 86.2 86.2
US
Abbvie Inc
NYSE:ABBV
287.4B USD 5.3 59.6 12.9 19.7
US
Amgen Inc
NASDAQ:AMGN
160.6B USD 5.4 42.7 18.2 29.9
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
105.6B USD 8.1 27.4 22.1 24.5
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
103.7B USD 10.5 28.7 22.9 24
AU
CSL Ltd
ASX:CSL
135.1B AUD 6.3 36.2 21.9 27.1
US
Gilead Sciences Inc
NASDAQ:GILD
81.7B USD 3 168.7 6.8 8.9
US
Moderna Inc
NASDAQ:MRNA
46.8B USD 9.1 -7.8 -8.5 -7.6
US
Seagen Inc
NASDAQ:SGEN
43.1B USD 18.8 -57.5 -61.9 -55.8
US
Biogen Inc
NASDAQ:BIIB
32.2B USD 3.3 27.6 14.1 17.7
KR
Celltrion Inc
KRX:068270
40.2T KRW 18.5 75.1 45.9 63.2

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 135,000+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.